title: Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
authors.affiliation: Second Department of Psychiatry Medical School, University of Athens Attikon University General Hospital Athens, Greece yanmih@yahoo.com Second Department of Psychiatry Medical School, University of Athens Attikon University General Hospital Athens, Greece First Department of Psychiatry Medical School, University of Athens Eginition Hospital Athens, Greece Second Department of Psychiatry Medical School, University of Athens Attikon University General Hospital Athens, Greece.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Michopoulos
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Ferentinos
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Oulis
authors.forename: Rossetos
authors.initials: R
authors.lastname: Gournellis
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines / Q000008:administration & dosage; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003511:Cyclohexanols / Q000009:adverse effects*; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000009:adverse effects*; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D000077152:Olanzapine; D000069348:Quetiapine Fumarate; D012148:Restless Legs Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003511:Cyclohexanols; D003987:Dibenzothiazepines; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D000069470:Venlafaxine Hydrochloride; D000077152:Olanzapine